3/4/2025HighTide Thera Publishes Positive Phase 2 Data on HTD1801 for Type 2 D...

3/4/2025BeiGene's TEVIMBRA Approved in U.S. for First-line Treatment of Advanc...

3/4/2025The United Labs' UBT251 Injection Receives FDA Approval for Phase II C...

3/4/2025Longbio Pharma's LP-003 Shows Promising Results in Phase II CSU Trial

3/4/2025Bioray's BR111: Pioneering Dual-Epitope ADC for ROR1-Positive Cancers

3/4/2025Hansoh Pharma's HS-20089 Advances to Phase III Trial for Platinum-Resi...

3/4/2025Trump's 'America First' Investment Policy Raises Uncertainty for US-Ch...

3/3/2025Innovent's IBI363 Enters Pivotal Trial, Challenging Keytruda in Melano...

2/28/2025Duality Biologics Withdraws Hong Kong IPO Plans Amidst Strategic Partn...

2/28/2025NMPA Approves Multiple Drugs for Cancer, Cardiovascular, and Liver Dis...

2/28/2025CDE Seeks Public Feedback on "SPARK Initiative" to Boost Pediatric Onc...

2/28/2025Recent Executive Moves

2/28/2025Henlius Initiates Phase 1b/2 Trial for PD-L1 ADC HLX43 in Solid Tumors

2/28/2025SciClone Secures Rights to Eisai's Tasurgratinib for Greater China

2/28/2025China's Tech Giants Look to Healthcare (The Wire China)

2/28/2025Pace, Price of China Licensing Deals Continues to Rise (BioCentury)

2/27/2025Fail to Launch: Affordable Gene Therapy from China - A Realty Within R...

2/27/2025IVIEW Thera Reports Positive Phase 1/2 Results for IVW-1001 Ophthalmic...

2/27/2025HBM Alpha Enters License Deal to Advance Novel Endocrine Therapies

2/27/2025Henlius Registers Phase 3 Trials for Keytruda and Yervoy Biosimilars

2/27/2025Biokin (SystImmune) Initiates First Autoimmune Clinical Trial for Tetr...

2/27/2025Akeso Initiates First-in-Human Phase 1 Trial for HER3-Targeting ADC AK...

2/27/2025Novartis' NDA for BTK Inhibitor Remibrutinib Accepted by NMPA

2/27/2025Takeda Expands Partnership with BridGene to Tackle Hard-to-Drug Target...

2/26/2025In Vivo Gene Editing Product ART002 Achieves Saturation of Pharmacolog...

2/26/2025Former NMPA Deputy Commissioner Under Investigation

2/26/2025YolTech Therapeutics Announces Positive Clinical Data for In Vivo Gene...

2/26/2025Hengrui Reports Promising Results for Trastuzumab Rezetecan in HER2-Mu...

2/26/2025Chinese Biotech Firms Cash in on Promising Drug Discoveries via Licens...

2/25/2025XellSmart Secures Second FDA IND Approval for iPSC-Derived ALS Therapy...

Page:22/775 Total number of articles:23233: [First][<<] [20] [21] [22] [23] [24] [>>] [End]